Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-12 Sale |
2025-03-14 4:30 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
6,884 | $1.14 | $7,848 | 54,786 (Direct) |
View |
| 2024-03-28 Sale |
2024-04-01 9:30 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
1,614 | $4.6151 | $7,449 | 44,775 (Direct) |
View |
| 2024-03-25 Sale |
2024-03-27 6:59 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
2,475 | $4.67 | $11,558 | 42,212 (Direct) |
View |
| 2020-06-23 Purchase |
2020-06-25 5:59 pm |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
5,000 | $20 | $100,000 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-02 Option Award |
2025-04-04 4:15 pm |
N/A 2035-04-01 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
500,000 | $0 | 500,000 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-06 5:00 pm |
N/A 2035-03-03 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
299,000 | $0 | 346,670 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-05 4:15 pm |
N/A 2034-02-28 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER |
99,000 | $0 | 129,687 (Direct) |
View |
| 2023-01-30 Option Award |
2023-02-01 9:44 pm |
N/A 2033-01-29 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
135,580 | $0 | 141,737 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:45 pm |
N/A 2032-01-17 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 9:07 pm |
N/A 2031-02-08 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
71,000 | $0 | 71,000 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 08:04 am |
N/A 2030-06-18 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
41,240 | $0 | 41,240 (Direct) |
View |
Ownership |
2020-06-18 9:28 pm |
N/A 2029-10-28 |
Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer |
0 | $0 | 325,800 (Direct) |
View |